Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Peritoneal carcinosis free survival
5 years
No
Alfred Königsrainer, MD
Principal Investigator
University Hospital Tuebingen
Germany: Federal Institute for Drugs and Medical Devices
2011-004405-25
NCT01683864
September 2012
September 2020
Name | Location |
---|